Daisuke Yamashita
CEO @ Next Innovation
Daisuke Yamashita is a angel investor at Next Innovation focused on Medical and Internet. Daisuke Yamashita - CEO @ Next Innovation
- Total investments:
- 2
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Daisuke Yamashita invests in
Stages Daisuke Yamashita invests in
Countries Daisuke Yamashita invests in
Investment Focus
Industry
- Medical 1 (50%)
- Internet 1 (50%)
- Education 1 (50%)
- Consulting 1 (50%)
- Health Care 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Next Innovation is an investment firm that focuses on the education sector. | Angel | |
|
|
Next Innovation is an online consulting provider for health care. | Angel |
About Next Innovation
Next Innovation is an investment firm that focuses on the education sector.
Next Innovation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Daisuke Yamashita invest in?
Daisuke Yamashita invests primarily in Medical, Internet and Education startups, most often at Angel stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!